Peer Reviewed Cancer
FY25 Advancing Cancer Care through Clinical Trials Award
The list of Fiscal Year 2025 Peer Reviewed Cancer Research Program Advancing Cancer Care through Clinical Trials Award applications recommended for funding is for informational purposes only. Identification on the list of applications recommended for funding is not intended to either confer a right to funding nor does it guarantee funding. The award of federal funds to support any of these applications is contingent upon successful negotiations and applicable federal policy.
| Institution | Principal Investigator |
|---|---|
| Dana-Farber Cancer Institute | Robbie Majzner |
| Dana-Farber Cancer Institute | Susanne Baumeister |
| Health Research, Inc., Roswell Park Division | Brian Betts |
| Marker Therapeutics, Inc. | Manali Kamdar |
| Missouri Pharmacy Association | Anne Eisenbeis |
| Northwestern University | Brett Ecker |
| Northwestern University | Karan Dixit |
| University of Michigan | Thomas Wang |
Last updated Friday, March 20, 2026